Form 4 · Filed Jun 8, 2026, 10:01 PM UTC
BBIO/BridgeBio Pharma, Inc.
Kumar Neil — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
14 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | S | sell | 7,147 | $67 | $480,271 | 528,539 |
| Jun 5, 2026 | S | sell | 8,437 | $68 | $572,744 | 520,102 |
| Jun 5, 2026 | S | sell | 4,416 | $69 | $304,524 | 515,686 |
| Jun 5, 2026 | S | sell | 7,148 | $67 | $480,338 | 4,331,299 |
| Jun 5, 2026 | S | sell | 8,437 | $68 | $572,744 | 4,322,862 |
| Jun 5, 2026 | S | sell | 4,415 | $69 | $304,455 | 4,318,447 |
| Jun 4, 2026 | S | sell | 15,921 | $68 | $1,078,452 | 4,338,897 |
| Jun 4, 2026 | S | sell | 2,200 | $66 | $144,584 | 553,486 |
| Jun 4, 2026 | S | sell | 450 | $68 | $30,721 | 4,338,447 |
| Jun 4, 2026 | S | sell | 1,429 | $67 | $95,347 | 552,057 |
| Jun 4, 2026 | S | sell | 15,921 | $68 | $1,078,454 | 536,136 |
| Jun 4, 2026 | S | sell | 450 | $68 | $30,721 | 535,686 |
| Jun 4, 2026 | S | sell | 2,200 | $66 | $144,584 | 4,356,247 |
| Jun 4, 2026 | S | sell | 1,429 | $67 | $95,347 | 4,354,818 |
Source: SEC EDGAR raw filing ↗ · Accession 0001470831-26-000523